Molecular and immunohistochemical effects of metformin in a rat model of type 2 diabetes mellitus

  • Authors:
    • Tamer Ahmed Ismail
    • Mohamed Mohamed Soliman
    • Mohamed Abdo Nassan
  • View Affiliations

  • Published online on: March 13, 2015     https://doi.org/10.3892/etm.2015.2354
  • Pages: 1921-1930
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Type 2 diabetes mellitus (T2DM) is a serious health issue worldwide. The disease is characterized by insulin resistance (IR), which leads to dyslipidemia and alterations in the expression levels of a number of genes. Metformin is the standard treatment for T2DM; however, the exact mechanism underlying metformin regulation is not fully understood. The aim of the present study was to investigate the effects of metformin on serum lipid profiles and the expression levels of various genes that are associated with IR, as well as the histopathological changes in the liver and pancreas. A T2DM rat model was established by feeding the rats a high‑fat diet for 4 weeks, combined with a dose of streptozotocin (35 mg/kg body weight). Following the successful induction of T2DM, metformin was administered orally (400 mg/kg/day) for 4 weeks. The results indicated that metformin improved the symptoms of IR by normalizing the serum lipid profiles in the diabetic rats. Furthermore, metformin upregulated the expression of insulin receptors and genes associated with lipid metabolism, including acyl‑CoA oxidase, carnitine palmitoyl transferase‑1 and peroxisome proliferator activated receptor‑α. In addition, treatment with metformin downregulated the expression levels of fetuin‑A and retinol binding protein‑4 (RBP‑4), while normalizing the expression of perilipin that had been reduced in the T2DM rats. Metformin administration induced regenerative changes in the hepatocyte cytoplasm and parenchyma. In the pancreas, treatment with metformin was shown to induce positive signaling for insulin and the regeneration of pancreatic β cells. In summary, metformin treatment ameliorated a number of the harmful effects associated with T2DM via the modulation of the expression levels of fetuin‑A, RBP‑4, perilipin and various genes associated with lipid metabolism, resulting in regenerative changes in the liver and pancreatic cells.
View Figures
View References

Related Articles

Journal Cover

May-2015
Volume 9 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ismail TA, Soliman MM and Nassan MA: Molecular and immunohistochemical effects of metformin in a rat model of type 2 diabetes mellitus. Exp Ther Med 9: 1921-1930, 2015
APA
Ismail, T.A., Soliman, M.M., & Nassan, M.A. (2015). Molecular and immunohistochemical effects of metformin in a rat model of type 2 diabetes mellitus. Experimental and Therapeutic Medicine, 9, 1921-1930. https://doi.org/10.3892/etm.2015.2354
MLA
Ismail, T. A., Soliman, M. M., Nassan, M. A."Molecular and immunohistochemical effects of metformin in a rat model of type 2 diabetes mellitus". Experimental and Therapeutic Medicine 9.5 (2015): 1921-1930.
Chicago
Ismail, T. A., Soliman, M. M., Nassan, M. A."Molecular and immunohistochemical effects of metformin in a rat model of type 2 diabetes mellitus". Experimental and Therapeutic Medicine 9, no. 5 (2015): 1921-1930. https://doi.org/10.3892/etm.2015.2354